EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen

Junpu Li, Yan Guo

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1658070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Junpu Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical Laboratory, Tianjin Chest Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Mannans, Antigens, Fungal, Luminescent Measurements, Aspergillus. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Invasive pulmonary aspergillosis (IPA) poses significant diagnostic challenges in immunocompromised patients, with galactomannan (GM) detection serving as a key biomarker. Existing Platelia™ GM enzyme-linked immunosorbent assay (ELISA) faces limitations in throughput and turnaround time.

Methods

We developed a magnetic bead-based chemiluminescent enzyme immunoassay (CLEIA) for GM detection in serum/bronchoalveolar lavage fluid (BALF).

Results

Optimized CLEIA parameters enabled 30-min analysis versus 120-min for ELISA. Validation with 241 clinical specimens demonstrated robust analytical performance: diagnostic thresholds of ≥ 0.20 CLEIA Units for serum and BALF matrices (ROC-AUC 0.87, p<0.0001), analytical sensitivity of 0.50 ng/mL, and precision with ≤14.40% total CV, and no hook effect ≤200 ng/mL. Method comparison against the Platelia ELISA revealed 86.72% overall diagnostic agreement (Cohen’s k=0.72), while cross-reactivity analyses indicated specificity limitations exclusively with Histoplasma -positive specimens, consistent with parallel GM ELISA results.

Discussion

This assay enables 75% processing time reduction with uncompromised diagnostic accuracy, positioning it as a high-throughput alternative for rapid IA screening in high-risk cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MannansAntigens, FungalLuminescent MeasurementsAspergillusInvasive Pulmonary AspergillosisGalactoseHumansSensitivity and SpecificityBronchoalveolar Lavage FluidEnzyme-Linked Immunosorbent AssayImmunoassay

Stichwörter der Autor:innen

BALFchemiluminescentgalactomannanimmunoassayserum

Substanzen

galactomannanMannansGalactoseAntigens, Fungal

Autor:innen und Institutionen

  • The Clinical Laboratory, Tianjin Chest Hospital, Tianjin, China.
  • Department of Medical Ultrasound, Tianjin Medical University General Hospital, Tianjin, China.

Zitieren

APA

Li, J., & Guo, Y. (2025). Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1658070

Vancouver

Li J, Guo Y. Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1658070

BibTeX
@article{Li2025,
  author = {Li, Junpu and Guo, Yan},
  title = {Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1658070}
}
Kostenlos starten →